Urapidil | CAS#34661-75-1 | α-Adrenergic antagonist

MedKoo Cat#: 464537 | Name: Urapidil

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Urapidil is an α-Adrenergic antagonist and peripheral vasodilator.

Chemical Structure

Urapidil

CAS#34661-75-1 (free base)

Theoretical Analysis

MedKoo Cat#: 464537

Name: Urapidil

CAS#: 34661-75-1 (free base)

Chemical Formula: C20H29N5O3

Exact Mass: 387.2270

Molecular Weight: 387.48

Elemental Analysis: C, 61.99; H, 7.54; N, 18.07; O, 12.39

Price and Availability

Size	Price	Availability	Quantity
1g	USD 250.00	2 Weeks
5g	USD 650.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

34661-75-1 (free base) 64887-14-5 (HCl)

Synonym

Urapidil; Ebrantil; Eupressyl; Mediatensyl;

IUPAC/Chemical Name

6-((3-(4-(2-methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione

InChi Key

ICMGLRUYEQNHPF-UHFFFAOYSA-N

InChi Code

InChI=1S/C20H29N5O3/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-25(14-12-24)16-7-4-5-8-17(16)28-3/h4-5,7-8,15,21H,6,9-14H2,1-3H3

SMILES Code

O=C1N(C)C(C=C(NCCCN2CCN(C3=CC=CC=C3OC)CC2)N1C)=O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

To be determined

Shelf Life

>2 years if stored properly

Drug Formulation

To be determined

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 387.48 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Strauss M, Leischik R, Jehn U, Padberg JS, Pistulli R, Kümpers P, Reinecke H. Der hypertensive Notfall : Empfehlungen zum initialen medikamentösen Therapiemanagement [The hypertensive emergency situation : Recommendations for initial drug therapy management]. Med Klin Intensivmed Notfmed. 2020 Sep 17. German. doi: 10.1007/s00063-020-00728-6. Epub ahead of print. PMID: 32940723. 2: Lewek J, Bielecka-Dąbrowa A, Maciejewski M, Banach M. Pharmacological management of malignant hypertension. Expert Opin Pharmacother. 2020 Jul;21(10):1189-1192. doi: 10.1080/14656566.2020.1732923. Epub 2020 Feb 26. PMID: 32100590. 3: Salvetti M, Paini A, Bertacchini F, Stassaldi D, Aggiusti C, Agabiti Rosei C, Muiesan ML. Acute blood pressure elevation: Therapeutic approach. Pharmacol Res. 2018 Apr;130:180-190. doi: 10.1016/j.phrs.2018.02.026. Epub 2018 Feb 23. PMID: 29481963. 4: Niu X, Zhang J, Bai M, Peng Y, Sun S, Zhang Z. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis. BMC Cardiovasc Disord. 2018 Jan 10;18(1):3. doi: 10.1186/s12872-017-0722-z. PMID: 29320987; PMCID: PMC5763527. 5: Il'in SA. Urapidil kak preparat vybora dlia snizheniia arterial'nogo davleniia v khirurgicheskoĭ praktike [Urapidil as a drug of choice for decreasing arterial pressure in surgical practice]. Angiol Sosud Khir. 2017;23(4):147-158. Russian. PMID: 29240069. 6: Nottebaum BJ, Groeben H. Anästhesiologisches Management bei Phäochromozytomoperationen : Aktuelle Strategien [Anesthetic management during pheochromocytoma surgery : Current strategies]. Urologe A. 2016 Jun;55(6):723-31. German. doi: 10.1007/s00120-016-0082-9. PMID: 27165034. 7: Keller K, Desuki A, Hobohm L, Münzel T, Ostad MA. Acute episode of cyclic vomiting syndrome preceded by arterial hypertension – Case presentation and review. Neth J Med. 2015 Oct;73(8):379-82. PMID: 26478548. 8: Minushkina LO. [Treatment of hypertensive emergencies and malignant hypertension: the possibility of using urapidil]. Kardiologiia. 2014;54(11):70-4. Russian. doi: 10.18565/cardio.2014.11.70-74. PMID: 25902662. 9: Vertkin AL, Topolianskiĭ AV, Abdullaeva AU, Alekseev MA, Shakhmanaev KhA. [Hypertensive crisis: pathogenesis, clinic, treatment]. Kardiologiia. 2013;53(6):66-70. Russian. PMID: 23953048. 10: Nedogoda SV. [Place of urapidil in the treatment of hypertensive crises from the standpoint of clinical pharmacology and evidence-based medicine]. Kardiologiia. 2013;53(12):79-82. Russian. PMID: 24800486. 11: Minushkina LO. [Features of urapidil in treatment of resistant hypertension]. Kardiologiia. 2012;52(8):77-82. Russian. PMID: 23098404. 12: Kobalava ZhD, Kotovskaia IuV, Bagmanova NKh, Artiukhov OP, Darmaeva IP. [Hypertensive crisis in cardiology: place of urapidil]. Kardiologiia. 2012;52(1):86-90. Russian. PMID: 22304359. 13: Gregorini L, Marco J, Heusch G. Peri-interventional coronary vasomotion. J Mol Cell Cardiol. 2012 Apr;52(4):883-9. doi: 10.1016/j.yjmcc.2011.09.017. Epub 2011 Sep 24. PMID: 21971073. 14: Buch J. Urapidil, a dual-acting antihypertensive agent: Current usage considerations. Adv Ther. 2010 Jul;27(7):426-43. doi: 10.1007/s12325-010-0039-0. Epub 2010 Jun 28. PMID: 20652659. 15: Janota T. Hypertenzní krise--soucasný pohled [Hypertensive crisis--the present view]. Cas Lek Cesk. 2009;148(8):370-3. Czech. PMID: 19899722. 16: Link A, Selejan S, Walenta K, Reil JC, Böhm M. Therapie des peri- und postoperativen hypertensiven Notfalls [Treatment of peri- and postoperative hypertensive emergencies]. Dtsch Med Wochenschr. 2009 Apr;134(14):701-7. German. doi: 10.1055/s-0029-1208109. Epub 2009 Mar 24. PMID: 19319772. 17: Kuhlmann U, Hoyer J. Hypertensiver Notfall. Wie weit muss der Blutdruck runter? [Hypertensive emergency]. MMW Fortschr Med. 2008 Dec 11;150(51-52):47-8. German. PMID: 19149310. 18: Rath W, Bartz C. Therapeutisches Vorgehen bei schwerer Präeklampsie und beim HELLP-Syndrom [Treatment of severe preeclampsia and HELLP syndrome]. Zentralbl Gynakol. 2004 Oct;126(5):293-8. German. doi: 10.1055/s-2004-820420. PMID: 15478045. 19: Suwelack B, Welling U, Hohage H. Hypertensive Krise: was tun im Notfall? [Hypertensive crisis: what to do in emergencies?]. Med Klin (Munich). 2004 Sep 15;99(9):528-35; quiz 536. German. doi: 10.1007/s00063-004-1079-5. PMID: 15372182. 20: Kranke P, Eberhart LH, Roewer N, Tramèr MR. Single-dose parenteral pharmacological interventions for the prevention of postoperative shivering: a quantitative systematic review of randomized controlled trials. Anesth Analg. 2004 Sep;99(3):718-27, table of contents. doi: 10.1213/01.ANE.0000130589.00098.CD. PMID: 15333401.